Pharmaceuticals

Shukra Pharmaceuticals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 67 filings·Updated 6 Oct 2026
Showing 10 of 67 filings.
6 Oct 20262 filings
Company UpdatePrice movement

Significant movement in price has been observed in Shukra Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:39View Source
Company UpdateClarification

The Exchange has sought clarification from Shukra Pharmaceuticals Ltd on October 06, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:27
29 Sept 20262 filings
AGM/EGMPostal Ballot

Shukra Pharmaceuticals postal ballot approves MOA amendment and name change to Shukra Medtech

MOA object clause amendment

  • Type: Special resolution; Purpose: amend object clause of the MOA.
  • Outcome: Approved; 99.9710% in favour (1,07,55,536 votes), 0.0290% against (3,116).

Name change to Shukra Medtech Limited

  • Type: Special resolution; Change of name to Shukra Medtech Limited with MOA/Articles amendments.
  • Outcome: Approved; 99.9610% in favour (84,75,349 votes), 0.0390% against (3,303).
Filed 19:49View Source
AGM/EGMAGM

Shukra Pharmaceuticals AGM 2026 approves financials, dividend, and director appointments via VC/OAVM

AGM details

  • Date/time/mode: Sep 28, 2026, 12:00 PM, VC/OAVM.
  • Record date: Sep 21, 2026.
  • Shareholders on record: 33,659.
  • Attendees via VC: Promoter group 3; Public 45.
  • Scrutinizer: Rupal Patel.
  • Resolutions passed: 4.

Resolutions and outcomes

  • Resolution 1: Adoption of Audited Financial Statements for FY ended 31 Mar 2026 (ordinary).
  • Resolution 1 outcome: Passed; one dissenting vote.
  • Resolution 2: Approve final dividend for FY 2025-26.
  • Resolution 2 outcome: Passed; two votes against (350 shares).
  • Resolution 3: Re-appointment of Sanskruti Patel as Executive Director; retires by rotation.
  • Resolution 3 outcome: Passed; 260 shares against.
  • Resolution 4: Regularisation of Additional Independent Director Dinesh Chauhan; Special Resolution.
  • Resolution 4 outcome: Passed; 260 shares against.

Director changes

  • Sanskruti Patel re-appointed as Executive Director; retires by rotation.
  • Dinesh Chauhan Regularised as Additional Independent Director.
Filed 18:42View Source
28 Sept 20261 filing
Board MeetingOutcome of Board Meeting

Shukra Pharmaceuticals approves FY2025-26 audited statements, declares final dividend, and reappoints directors at AGM

AGM outcomes

  • Audited financial statements for FY ended 31 March 2026 approved; Board and Auditor reports adopted.
  • Final dividend for FY 2025-26 approved.
  • Audit report shows no qualification, reservation, or adverse remarks.
  • No shareholder queries were raised during the AGM.

Director appointments

  • Re-appointment of Sanskruti Patel as Executive Director; retires by rotation.
  • Regularization of Dinesh Chauhan as Independent Director.

AGM logistics

  • 33rd AGM held via VC on Sep 28, 2026; voting results to be announced within 48 hours.
  • Chairman Dhruvin Shah chaired the meeting; Scrutinizer appointed for voting.
Filed 20:33View Source
24 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Shukra Pharmaceuticals Ltd closes trading window from Oct 1, 2026 till 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2026.

Shukra Pharmaceuticals Ltd closes trading window from Oct 1, 2026 till 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2026.

Filed 18:52View Source
23 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:45View Source
22 Sept 20261 filing
AGM/EGMPostal Ballot

Shukra Pharmaceuticals postal ballot seeks MOA alteration and name change to Shukra Medtech

Key resolutions and updates

  • Purpose: postal ballot for MOA alteration and name change to Shukra Medtech.
  • Resolutions: two special resolutions—MOA alteration and change of company name with MOA/AOA amendments.
  • Corrigendum updates Annexure-A with Revised Auditor's Certificate per BSE/SEBI formatting.
  • Remote e-voting window: Aug 28, 2026 to Sep 26, 2026.
  • Votes cast earlier may be superseded; shareholders may re-vote under revised certificate.
  • No share capital or other financial actions disclosed in this corrigendum.
  • No director appointments, related-party transactions, or governance changes disclosed.
Filed 18:26View Source
18 Sept 20261 filing
Corp. ActionRecord Date

Shukra Pharmaceuticals fixes Record Date for final dividend; Rs 0.01 per share, subject to AGM approval

Record Date for Final Dividend

  • Purpose: determine eligibility for Final Dividend for FY 2025-26.
  • Security: Equity shares.
  • Record date: Monday, 21 September 2026.
  • Dividend: final dividend of Rs 0.01 per equity share (face value Rs 1).
  • AGM: 33rd AGM on Monday, 28 September 2026.
  • Dividend is subject to approval by shareholders at AGM.
  • Paid to members as on the record date.
Filed 14:58View Source
3 Sept 20261 filing
AGM/EGMAGM

Shukra Pharmaceuticals reschedules 33rd AGM to Sept 28, 2026 with VC/OAVM mode and revised book closure

AGM Details

  • New AGM date: 28 September 2026 at 12:00 PM IST; mode: VC/OAVM.
  • Revised book closure: 22 September 2026 to 28 September 2026 inclusive.
  • Remote e-voting period to be adjusted; final Notice will provide details.

Scrutinizer

  • Mrs. Rupal Patel remains Scrutinizer, appointment approved by the board on 22 August 2026.

Other Updates

  • Remote e-voting timing and cut-off will align with the revised AGM date.
Filed 20:06View Source
Showing 10 of 67 filings